Lantheus
Curated by SignalDeveloper of diagnostic imaging agents and targeted therapeutics
Overview
Developer of diagnostic imaging agents and targeted therapeutics. The company's lead candidate is PNT2002 a small molecule PSMA-targeted 177Lu-based radioligand therapy for metastatic castration-resistant prostate cancer. It also offers software like DEFINITY, VIALMIX, PINSYNC, TechneLite, and more. It offers imaging agents that assist in the diagnosis of heart and vascular diseases with nuclear imaging, echocardiography, and magnetic resonance imaging (MRI) technologies.
Key facts
- Founded
- 1956
- Headquarters
- Billerica, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view
Open roles
129 rolesExecutive Director, Head of Clinical Development - Oncology
Greater Boston · On-site · Volunteer
Clinical Research, Senior Principal Scientist (Director), Oncology
Bedford, MA · On-site · Volunteer
Key Account Manager- Nuclear Medicine
Seattle, WA · On-site · Volunteer